MMP1 and breast carcinoma: Additionally, MMP1 upregulation was reported to enhance multi-drug resistance to MCF-7 breast cancer cells, as evidenced by the increase of the IC50 values of ADR, vincristine, and paclitaxel in MCF-7 breast cancer cells overexpressing MMP1 [205].